- L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published by the Lancet https://www.thelancet.com/journals/eclinm/article/piis2589-5370(21)00405-3/fulltext 44 comments worldnews
- L-arginine, an off-patent, low cost and safe nutraceutical, reduces need for respiratory support and length of hospitalisation for COVID-19 by almost 50% in a recent RCT published in the Lancet https://www.thelancet.com/journals/eclinm/article/piis2589-5370(21)00405-3/fulltext 113 comments science
- Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis https://www.thelancet.com/journals/eclinm/article/piis2589-5370(21)00405-3/fulltext 3 comments science
Linking pages
- Using Pay-For-Success Contracts to Create Open Source Medicines by Repurposing Off-Patent Drugs | by Crowd Funded Cures | Medium https://crowdfundedcures.medium.com/pay-for-success-contracts-a-new-model-to-develop-new-therapies-from-old-drugs-f69b2189184d 30 comments
- On the Treatment of Covid-19 https://swprs.org/on-the-treatment-of-covid-19/ 4 comments